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Lina Xiang1†, Rachel W S Chan1,2*†, Ernest H Y Ng1,2 and William S B Yeung1,2Abstract
Introduction: Evidence suggests that the human endometrium contains stem or progenitor cells that are
responsible for its remarkable regenerative capability. A common property of somatic stem cells is their quiescent
state. It remains unclear whether slow-cycling cells exist in the human endometrium. We hypothesized that the
human endometrium contains a subset of slow-cycling cells with somatic stem cell properties. Here, we established
an in vitro stem cell assay to isolate human endometrial-derived mesenchymal stem-like cells (eMSC).
Methods: Single-cell stromal cultures were initially labeled with fluorescent nanoparticles and a small population of
fluorescent persistent cells (FPC) remained after culture of 21 days. Two populations of stromal cells, namely FPC
and non-FPC were sorted.
Results: Quantitative analysis of functional assays demonstrated that the FPC had higher colony forming ability,
underwent more rounds of self-renewal and had greater enrichment of phenotypically defined prospective eMSC
markers: CD146+/CD140b+ and W5C5+ than the non-FPC. They also differentiate into multiple mesenchymal
lineages and the expression of lineage specific markers was lower than that of non-FPC. The FPC exhibit low
proliferation activities. A proliferation dynamics study revealed that more FPC had a prolonged G1 phase.
Conclusions: With this study we present an efficient method to label and isolate slow-proliferating cells obtained
from human endometrial stromal cultures without genetic modifications. The FPC population could be easily
maintained in vitro and are of interest for tissue-repair and engineering perspectives. In summary, nanoparticle
labeling is a promising tool for the identification of putative somatic stem or progenitor cells when their surface
markers are undefined.Introduction
Somatic tissues are comprised of connective tissue or
stromal components, and mesenchymal stem cells of the
stroma are believed to be responsible for tissue regener-
ation and remodeling [1]. The inner mucosal lining of
the uterus is the endometrium, which consists of epithe-
lial and mesenchymal stromal cells. The endometrium
displays remarkable regenerative capacity during the
reproductive years of a woman [2]. Stem/progenitor cells
residing in the lower basalis layer of the endometrium are
believed to be responsible for the cyclic growth after men-
struation [3]. Recently, subpopulations of the endometrial* Correspondence: rwschan@hku.hk
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unless otherwise stated.stromal cells have been shown to exhibit properties of
mesenchymal stem cells [4,5]. Human bone marrow-
derived cells can also incorporate into the endometrium
in low numbers [6,7]. Therefore, there is an emerging con-
cept that the human endometrial-derived mesenchymal
stem-like cells (eMSC) are responsible for the cyclical
regeneration of the human endometrium [5].
Somatic stem cells are characterized by their dual abilities
to self-renew and to differentiate into progenitors of various
lineages [8]. During differentiation, somatic stem cells
divide asymmetrically to give rise to two daughter cells with
different cell fates [9]. One daughter cell is a copy of the
original stem cell and continues to function as a stem cell,
while the other differentiates, divides and gives rise to
mature cells. It is commonly accepted that somatic stem
cells are usually quiescent in nature [10]. Their infrequent
division would prevent them from exhaustion during tis-
sue regeneration and repair. However, rapidly regeneratingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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stem cell feature [11,12]. Currently, there is no study on
the cycling kinetics of endometrial stem cells.
We hypothesize that eMSC are slow-cycling. In mouse
endometrium, the existence of slow-cycling stem-like
cells has been reported [13-15]. However, traditional
tracking tools for human tissue stem cells without
definitive cell surface markers cannot isolate candidate
somatic stem cells for functional investigation. To over-
come this obstacle we developed a method for the isola-
tion of eMSC based on their slow-cycling property. In
this study, we use fluorescent nanoparticles for tracking
slow-cycling cells in a live heterogeneous population of
endometrial stromal cells. The fluorescence of the nano-
particles is bio-stable and photo-stable. Therefore, it can
be tracked even after a prolonged period of culture with-
out perturbing cellular function [16]. In addition, these
nanoparticles are randomly distributed among daughter
cells without altering the differentiation potential of the
stem cells [17]. We postulated that the loaded nanoparti-
cles would persist in the slow-cycling cells (fluorescent per-
sistent cells, FPC) but dilute to an undetectable level in the
actively-proliferating cells (non-FPC), such as progenies of
eMSC. Here, we report the successful use of nanoparticles
for the isolation of a subset of endometrial-derived mesen-
chymal stromal cells with somatic stem cell properties. In
the initial part of this study, we compared the fluorescence
signals in the endometrial stromal cells after cultivation for
15 and 21 days to determine the optimal dilution time for
cells to undergo sufficient rounds of cell division. In the
later part of the study, post-labeled cells cultivated for




Human endometrial tissue was collected from 19 ovulating
women, 35- to 49-years old undergoing hysterectomy for
non-endometrial pathologies, who had not taken hormonal
therapy for three months before surgery. Ethical approval
was obtained from the Institutional Review Board of the
University of Hong Kong/Hospital Authority Hong Kong
West Cluster. Informed written consent was obtained
from each patient. The stage of the menstrual cycle was
categorized into proliferative (n = 7) and secretory (n = 12)
by experienced histopathologists based on hematoxylin-
eosin-stained endometrial sections. The histological cri-
teria for endometrial dating of the menstrual phase were
according to Noyes et al. [18].
Preparation of single cell suspensions of human
endometrial stromal cells
The endometrium was scraped off from the underlying
myometrium, minced and digested in PBS containingcollagenase type I (300 μg/mL, Sigma-Aldrich, St Louis,
MA, USA) and deoxyribonuclease type I (40 μg/mL,
Roche Diagnostics, Mannheim, Germany) for one hour at
37°C, as described previously [19]. Ficoll-Paque (GE
Healthcare, Uppsala Sweden) density-gradient centrifuga-
tion was used to remove red blood cells. Endometrial
stromal cells were selected using negative selection with
epithelial marker anti-EpCAM antibody-coated Dynabeads
(Clone BerEP4, Invitrogen, Grand Island, NY, USA) and
elimination of leukocytes using anti-CD45 antibody-coated
Dynabeads (Invitrogen).
Qtracker® labeling and tracking
A portion of the freshly purified endometrial stromal cell
suspension was loaded with commercially available nano-
particles (Qtracker® 655 cell labeling kit, Invitrogen), while
the other portion of cells was used a control. The reagents
in the kit use a targeting peptide to deliver red-fluorescent
nanoparticles into the cytoplasm of live cells. Qtracker® re-
agent A and B were premixed following the manufacture’s
instruction and incubated with one million stromal cells
containing fresh growth medium, DMEM-F12 medium
(Sigma-Aldrich) containing 10% FBS (Gibco, Grand
Island, NY, USA), 1% antibiotics (Gibco) and 2 mmol/L
glutamine (Gibco). The cells were incubated with the dye
solution for 45 minutes at 37°C, after which cells were
washed twice with growth medium. About 2 × 105 cells
were then plated into 100-mm petri dishes (BD Biosciences,
San Jose, CA, USA) coated with gelatin. Cells were cul-
tured in growth medium at 37°C in a humidified car-
bon dioxide incubator. Medium was changed every seven
days.
Regular monitoring of the Qtracker® dye in the stromal
cell culture was conducted every three to four days using
an Eclipse TE300 inverted microscope (Nikon, Tokyo,
Japan). The petri dish containing the cultured cells was di-
vided into ten areas and images of the cells within the areas
were acquired with the Image-Pro-Plus 6.0 software (Media
Cybernetics, Warrendale, PA, USA). The Qtracker® fluores-
cence labeling indexes after culturing for 0, 1, 3, 6, 8,
15 and 21 days were determined by dividing the number
of fluorescence+ cells by the total number of cells counted.
Four plates of cells from each day were counted.
Fluorescence-activated cell sorting analysis
Endometrial stromal cells labeled with the Qtracker® dye
were cultured for 15 and 21 days and fluorescence-activated
cell sorting (FACS) was performed in the University
of Hong Kong Core Facility with a FACSAria I flow cyt-
ometer (BD Biosciences) using the FACSDIVA software
(BD Biosciences). The cells were selected with electronic
gating according to the forward and the side scatter
profiles (Additional file 1: Figure S1A and S1B) using the
BD diva software (BD Biosciences). Freshly labeled cells
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trol (Additional file 1: Figure S1C), while the unlabeled
cells were used as the negative control (Additional file 1:
Figure S1D). Cells were incubated with propidium iodide
(PI) to exclude non-viable cells. Based on their fluorescence
intensities, FPC and non-FPC were sorted (Additional
file 1: Figure S1E). The purity of each sample was > 90%.
FACS data were analyzed using the FlowJo software (Tree
Star, Ashland, OR, USA).
Colony initiating cell assay
For assessment of colony-forming ability, FACS sorted
endometrial stromal FPC and non-FPC from post-labeled
day 15 (D15) and day 21 (D21) were plated at a clonal
density of 50 cells/cm2 onto gelatin coated 100-mm petri
dishes and cultured for 15 days. Cells were incubated at
37°C in 5% carbon dioxide with the culture medium chan-
ged every seven days. Regular monitoring of the cells was
performed under an inverted microscope (Nikon) to
identify colonies derived from single cells. Colony-forming
units (CFU) were stained with toluidine blue (Sigma-
Aldrich) on day 15. Large CFU were defined as colonies
with > 4,000 cells and small CFU were those with < 4,000
cells [19]. The colony forming ability was determined by
the number of CFU formed divided by the number of cells
seeded, multiplied by 100.
In vitro serial cloning
Individual large and small CFU from passage 1 (P1) were
trypsinzed using cloning rings (Sigma-Aldrich) to deter-
mine the self-renewal capacity of cells from endometrial
stromal FPC and non-FPC. Colonies collected from post-
labeled D15 and D21 were assessed. The cell number of
each CFU was determined and the cells were re-seeded
onto gelatin-coated dishes at a density of 20 cells/cm2 and
cultured for a further 15 days for formation of clones in
the secondary passage (P2). This process continued until
the cells could no longer form CFU.
Fluorescence-activated cell sorting analyses of
endometrial mesenchymal stem-like cell marker
expression
The expression level of prospective endometrial mesenchy-
mal stem cell markers (co-expression of CD146/CD140b
and W5C5) on endometrial stromal cells post-label
D21 (P0) were analyzed using multicolor flow cytom-
etry. Dissociated cells were re-suspended at a concen-
tration of 2 × 106 cells/ml in 0.1% BSA/PBS and incubated
with antibodies against fluorescein isothiocyanate (FITC)-
conjugated anti-CD146 (1 mg/ml, P1H12 clone, mouse
immunoglobulin G1 (IgG1), Abcam, Cambridge, UK),
phycoerythrin (PE)-conjugated anti-platelet-derived growth
factor beta (PDGFRβ) (CD140b, 2.5 μg/ml, PR7212 clone,
mouse IgG1, R&D Systems, Minneapolis, MN, USA)and PE-conjugated anti-mesenchymal stem cell (W5C5,
mouse IgG1, Biolegend, San Diego, CA, USA) in the
dark for 45 minutes on ice. Isotype matched controls
were included for each antibody. The cells were then
washed with 0.1% BSA/PBS three times (five minutes
each) and kept in 200 μl of 0.1% BSA/PBS for flow cyto-
metric analysis using the BD FACS Aria I (BD Biosci-
ences). Gating setting of fluorescence label cells, negative
and positive controls of stromal cells were prepared as
described above.
Total proliferative potential
The proliferative potential of CFU derived from the
endometrial stromal FPC and the non-FPC were exam-
ined by separately pooling 10 to 15 large CFU and 20 to
30 small CFU, then expanding them in culture seeding
at 2,000 cells/cm2 in triplicates of six-well plates. Only
chase D21 P1 cells were used. They were passaged every
eight to twelve days when the cultures reached 70% to
90% confluence. The process was continued until senes-
cence of the cells. The numbers of cells at each passage
were determined.
Determination of proliferation activity
Trypan blue exclusion assay
Clonally derived cells from D21 P2 were used to deter-
mine the proliferation activity of the endometrial stro-
mal FPC and the non-FPC. Unselected stromal cells
from the same passage were used as control. Cells were
seeded at 50 cells/cm2 in triplicates of gelatin coated
12-well plates and cultured for 15 days. Cell growth was
photographed under an inverted microscope. Cell via-
bility was determined by the trypan blue exclusion
assay. Triplicate wells of viable cells for each popula-
tion of cells were counted on a hemocytometer after
trypsinization.
DNA proliferation assay
Clonally derived cells from D21 P2 FPC and non-FPC
were cultured for 15 days. The DNA content of the cell
was measured using the CyQUANT® NF Cell Prolifera-
tion Assay (Invitrogen). Briefly, the culture medium was
removed from triplicates of 12-well plates and 500 μl of
the dye solution was added into each well. The plate was
incubated at 37°C for 60 minutes and the absorbance
unit (AU) was measured on a microplate reader (Tecan,
Männedorf, Switzerland) with an excitation wavelength
of 485 nm and an emission wavelength of 530 nm.
Generation of Cdt1-expressing cells
To visualize the G1 phase of the cell cycle in living cells,
single clonally derived FPC and non-FPC from D21 chase
P2 from three patient samples were plated in six-well
plates (2 × 104 cells) and transduced with Premo™ CdC 10
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(Cdt1-RFP, Invitrogen) according to the manufacturer’s in-
structions. HeLa and unselected endometrial stromal cells
from P2 were used as controls for the analysis. HeLa cells
were grown in DMEM supplemented with 10% fetal bo-
vine serum (FBS) and 1% penicillin. Endometrial stromal
cells were cultured in the standard conditions described
above.Time lapse imaging of live Cdt1-expressing cells
To capture single Cdt1-expressing cells, high-speed spinning
disk wide field imaging was performed at the University
of Hong Kong Core Facility on a PerkinElmer system
(PerkinElmer Life and Analytical Sciences, Waltham, MA,
USA) at 18 hours post-fluorescence labeled. The micro-
scope stage incubation chamber was maintained at 37°C.
Phase-contrast and fluorescence images were recorded at
15-minute intervals. To quantify the duration of the G1
phase of individual Cdt1-expressing cells, the intensity of
the nuclear red fluorescence was determined within a period
of 42 hours. Cells that exhibited a gradual increase in the
fluorescence intensity to a maximum followed by a grad-
ual fading within the recording period were selected for
analysis. The length of the G1 phase was measured as the
time interval between the first frame with the appearance
of the fluorescence to the last frame with the dis-
appearance of the fluorescence within the recording
period (Additional file 2: Figure S2A). Cdt1-expressing
cells that displayed the following patterns were not in-
cluded for analysis: continuous fluorescence throughout
the recording period (Additional file 2: Figure S2B),
fluorescence at the beginning of the recording (Additional
file 2: Figure S2C), or fluorescence still observed at the
end of the recording (Additional file 2: Figure S2D).
Image analysis was performed by using the Image Pro Plus
software (Media Cybernetics, Rockville, MD, USA). The
time lapse recording of Cdt1-transduced HeLa cells re-
vealed a G1 duration (6.03 ± 3.5 hour, a total of n = 20/cell
from three experiments) similar to a previous report [20].Mesenchymal lineage differentiation assay
In vitro cell culture
The multipotency of endometrial stromal FPC and non-
FPC was tested in vitro using clonally derived cells from
D21 P2 chase. Large CFU were expanded in normal cul-
ture conditions until 80% confluence. Cells were trypsi-
nized, re-seeded in triplicate at a seeding density of 200
cells/cm2 in six-well plates and cultured in either adipo-
genic, osteogenic or myogenic induction medium for four
weeks as outlined in Additional file 3: Table S1 [21]. For
chondrogenic differentiation, 5 × 105 cells were centrifuged
as a micromass and cultured in chondrogenic induction
medium for four weeks. Some of the endometrial stromalcells were cultured in serum-containing medium for four
weeks and served as the undifferentiated control.
Histochemical and immunohistochemical staining
Assessment of multipotency on differentiated cells was
confirmed using histochemical stains: Oil Red O (Sigma-
Aldrich), safranin-O or immunohistochemical stains using
antibodies against peroxisome proliferation activated re-
ceptor γ (PPARγ), alpha smooth muscle actin (αSMA)
(Dako Cytomation, Glostrup, Denmark), osteopontin
(Abcam), and collagen type II (Abcam) for adipogenic,
myogenic, osteogenic and chondrogenic differentiation,
respectively, as outlined in Additional file 3: Table S1.
After four weeks of culture in the respective induction
medium, the cells were fixed in 4% paraformaldehyde and
blocked with 10% serum (Sigma-Aldrich) to the host
species of the secondary antibody for 30 minutes. Pri-
mary antibodies (Additional file 4: Table S2) or isotype
matched control antibodies were incubated overnight at
4°C followed by the corresponding secondary antibodies
(Additional file 4: Table S2) for one hour. Cells were then
incubated with the avidin biotin complex reagent (Vector
Laboratories, Burlingame, CA, USA) for 30 minutes and
positive immunoreactivities were visualized using 3, 3'-di-
aminobenzidine (DAB) substrate solution (Sigma-Aldrich)
counterstained with hematoxylin. All incubations were
performed at room temperature unless otherwise specified
and washes with PBS were conducted between each step.
The cells were examined under an Axioskop micro-
scope (Zeiss, Oberkochen, Germany) and images were
acquired with a Photometric CoolSNAP charge-coupled
device camera (Roper Scientific, Tucson, AZ, USA) using the
CoolSNAP version 1.1 software.
Western blot analysis
Proteins from in vitro differentiated FPC and non-FPC
were extracted with cell lysis buffer (Ambion, Grand Is-
land, NY, USA). The protein samples (5 μg) were mixed
with 5X SDS loading buffer (60 mM Tris–HCl pH 6.8, 2%
SDS, 0.1% bromophenol blue, 25% glycerol and 14.4 mM
β-mercaptoethanol) and denatured at 95°C for 10 minutes.
Protein samples were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, and transferred to
polyvinylidene difluoride (PVDF) membranes. Mem-
branes were blocked with 5% skim milk (Nestle, Vevey,
Switzerland) in PBS containing 0.1% Tween-20 (PBST) for
30 minutes and incubated with primary antibodies at
appropriate concentrations (Additional file 5: Table S3)
overnight at 4°C. The membranes were stained with
appropriate horseradish peroxidase-conjugated secondary
antibodies (Additional file 5: Table S3) for one hour
at room temperature. The protein bands were visual-
ized by enhanced luminal-based chemiluminescence
(Westsave UP™; AbFrontier, Seoul, Korea). Endometrial
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were used as the control. Non-immune immunoglobu-
lin of the same isotype as the primary antibody was used
as negative control. The scanned Western blot bands
were quantified densitometrically and the values were
normalized to the amount of β actin using Image J soft-
ware (US National Institutes of Health, USA).
Quantitative real-time polymerase chain reaction
Quantitative real-time polymerase chain reaction (qPCR)
with Taqman probes was used to examine mesenchymal
lineage and pluripotent genes. Total RNA was extracted
with the Absolutely RNA RT-PCR microprep kit (Agilent
Technologies, Santa Clara, CA, USA). The quality and
quantity of the total RNA was checked by spectrophotom-
etry. The RNA was reverse transcribed by the high
capacity complementary DNA reverse transcription kit
(Roche Applied Science, Basel, Switzerland). Taqman
probes (Roche Applied Biosystems) were used to quantify
expression of the lineage (Additional file 3: Table S1) and
pluripotent (Additional file 6: Table S4) genes. Real-time
PCR was performed with a 7500 Real-Time PCR System
(Applied Biosystems, Grand Island, NY, USA) using the
following parameters: 2 minutes at 50°C, 10 minutes at
95°C, then 40 cycles of 15 seconds at 95°C and 1 minute
at 60°C. The results are presented as relative gene expres-
sion compared with internal control 18S using the 2-ΔΔCt
method [22]. Determination was made in triplicate from
three separate samples.
Statistical analysis
Data were analyzed using the GraphPad PRISM software
(version 5; GraphPad Software Inc., La Jolla, CA, USA). All
experiments were performed using at least three different
patient samples. The D’Agostino-Pearson test determined
that the data were not normally distributed. Non-
parametric Kruskal-Wallis one-way analysis of variance
followed by Mann Whitney was used to analyze the data.
P < 0.05 was considered as significantly different. Data are
expressed as means ± standard error of the mean (SEM).
Results
Nanoparticle-labeling identifies a population of
endometrial stromal FPC
Freshly isolated endometrial stromal cells at different
menstrual phases were loaded with the Qtracker® dye.
The distribution and pattern of the fluorescence signal in
the cells were assessed for 21 days. All the cells showed
100% intracellular punctuate red fluorescent signal at
24-hour post-labeling and the nanoparticles accumu-
lated in the perinuclear cytoplasm (Figure 1A, C, D). The
nanoparticles did not contribute to adverse effects on
proliferation or viability of post-labeled cells (data not
included). The percentage of cells declined rapidly to3.6 ± 0.8% over 15 days of culture (Figure 1A, E, F, G).
Only 0.8 ± 0.4% of the endometrial stromal cells retained
the fluorescence on D21 post-labeling (Figure 1A, H).
These stromal cells retaining the fluorescence are termed
FPC. The temporal change in the fluorescence labeling
index was similar in the endometrial stromal cells from the
proliferative and the secretory phases (Figure 1B). Based on
these results, chase periods of 15 and 21 days were selected
for comparison of the efficiency in obtaining an enriched
population of slow-proliferating cells from the culture.
Clonogenicity and self-renewal of endometrial stromal
FPC and non-FPC
Qtracker® loaded endometrial stromal cells were isolated
using FACS after D15 and D21 chases to generate the
FPC (Figure 1I) and the non-FPC (Figure 1J) populations.
The cell morphology of the two populations in culture
was similar. Single FPC and non-FPC were then subjected
to the in vitro colony forming assay. Figure 1K shows the
formation of clones after 15 days in culture, when clono-
genic clones can be depicted [19]. CFU were categorized into
large CFU > 4,000 cells (Figure 1L) and small CFU < 4,000
cells (Figure 1M).
The cloning efficiency was determined for the large
and small CFU from both populations. The percentage of
FPC that formed large CFU was 0.3 ± 0.1% (n = 4) at
chase-D15 and 0.6 ± 0.2% (n = 4) at chase-D21 (Figure 2A).
Although there was a trend of higher large CFU form-
ing ability with increased duration of chase, the increase
did not reach statistical significance (P = 0.34). The corre-
sponding cloning efficiencies of the non-FPC large CFU
were 0.3 ± 0.1% and 0.4 ± 0.1%, respectively (Figure 2B).
The cloning efficiencies for FPC small CFU at chase-
D15 (1.9 ± 0.3%) and chase-D21 (1.7 ± 0.5%) were similar
(Figure 2C). The cloning efficiencies of non-FPC small
CFU were also similar (D15: 2.7 ± 0.2%; D21: 3.2 ± 1.2%;
Figure 2D). There was no statistical difference in the
formation of small CFU for FPC (P = 0.69) and non-FPC
(P = 1.00) at the two chase periods.
The cloning efficiency of non-FPC small CFU at chase-
D15 was higher (2.7 ± 0.2%, Figure 2D) than FPC (1.9 ± 2.3,
P <0.05, Figure 2C). There was no statistical difference in
the formation of large CFU for FPC and non-FPC at chase
D15 (P = 0.62). There was also no differences between the
two populations for large (P = 0.58) and small (P = 0.68)
CFU at chase D21.
A better assessment of the somatic stem cell charac-
teristic was to quantify the self-renewal abilities of the
clonally derived cells in vitro. A total of four individual
large and small CFU per patient sample (n = 4) obtained
from the clonogenic assays were used. FPC large CFU
at chase-D21 underwent significantly more rounds of
self-renewal (5.0 ± 0.1) than those at chase-D15 (3.5 ±
0.3, P <0.05, Figure 2E). In contrast, non-FPC large CFU
Figure 1 Nanoparticle-labeled endometrial stromal cells. Qtracker® label of endometrial stromal cells. Quantitation of nanoparticle-labeled
endometrial stromal cells (A) with different duration of chase (n = 4 per time point) and (B) at different menstrual phases (n = 3, proliferative,
white; n = 3, secretory, black). Fluorescence expressing cells are reported as means ± SEM of the percentage of total stromal cells seeded. Day 1
post-labeled stromal cells stained with DAPI nuclei stain (blue) indicating the nanoparticles (red) are located in the cytoplasm (C). Representative
phase contrast images of nanoparticle-labeled stromal cells at different days in culture (D – H). Nanoparticle-labeled cells (arrows) detected on
day 1 (D) and then among the unlabeled stromal cells on day 3 (E), day 6 (F) and day 15 (G). Fluorescent signal retained at day 21 (H) (E - H).
Negative controls of unlabeled stromal cells are shown in the insets. Representative photographs of post-labeled day 21 endometrial stromal cells
after FACS analysis as FPC (I) and non-FPC (J) population in culture for five days. Culture dish displaying distribution of stromal colony forming
units (CFU) (K) after 15 days of culture. Morphology of large (L) and small (M) CFU. Scale bars = 50 μm (C, I, J) and 100 μm (D - H, L - M). DAPI,
4',6-diamidino-2-phenylindole; FACS, fluorescence-activated cell sorting; SEM, standard error of the mean.
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(3.5 ± 0.2) than those at chase-D21 (2.2 ± 0.1, P <0.05,
Figure 2F). For small CFU formed by FPC or non-FPC,
the self-renewal activities were significantly higher for
cells at chase-D15 (3.5 ± 0.3 and 3.5 ± 0.2, respectively)than those at chase-D21 (1.6 ± 0.2 and 2.1 ± 0.1, respect-
ively, P <0.05, Figure 2G, 2H).
The self-renewal activity for FPC large CFU at chase-
D21 was higher (5.0 ± 0.1%, Figure 2E) than non-FPC
(2.2 ± 0.1, P <0.05, Figure 2F), while the self-renewal
Figure 2 Clonogenicity and self- renewal ability of stromal FPC and non-FPC post-labeled day 15 and 21. (A – D) Cloning efficiency of
endometrial stromal cells post-labeled with nanoparticles at day 15 (white bars) and 21 (grey bars). Cloning efficiency of large CFU (A) FPC and
(B) non-FPC. Cloning efficiency of small CFU (C) FPC and (D) non-FPC. (E – H) Self-renewal activity of endometrial stromal cells post-labeled with
nanoparticles at day 15 (white bars) and 21 (grey bars) using serial cloning assay. Large CFU self-renewal ability of (E) FPC and (F) non-FPC. Small
CFU self-renewal ability of (G) FPC and (H) non-FPC Results reported as means ± SEM, n = 4, *, a, bP <0.05. CFU, colony-forming units; FPC, fluorescent
persistent cells; SEM, standard error of the mean.
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D15: large CFU (P = 0.89) and small CFU (P = 0.87) and
chase-D21 small CFU (P = 0.09).
Since FPC at chase-D21 displayed greater self-renewal
ability, they were used in subsequent experiments.
Endometrial stromal FPC exhibit greater self-renewal and
clonogenic activities
The self-renewal ability of endometrial stromal FPC large
CFU at chase-D21 (4.2 ± 0.4) was significantly higher than
that of the non-FPC large CFU (2.1 ± 0.1, P < 0.01, n = 7;
Figure 3A) when more samples were analyzed. The self-
renewal activity was also higher for the endometrial stro-
mal FPC small CFU (1.50 ± 0.13) than for the non-FPC
small CFU (1.1 ± 0.1, P < 0.05).
Next, we studied the sub-cloning characteristics of
the two populations post-label D21. In general, only
0.90 ± 0.09% (n = 19) of the endometrial stromal cells
were nanoparticle-labeled after 21 days. FPC large CFUformed clones in the first six rounds of recloning
and stopped thereafter (Figure 3B). Interestingly, sig-
nificantly higher cloning efficiencies of the endometrial
stromal FPC large CFU were observed in the secondary
(P2) and tertiary (P3) subcloning when compared with
that of the primary cloning (P1, Figure 3B, P <0.05).
These findings suggest that the freshly isolated FPC
population is enriched with stem/progenitor cells that
divide symmetrically to produce more stem/progenitor
cells resulting in higher cloning efficiency in P2 and P3.
The derived stem/progenitor cells subsequently pro-
duce transit amplifying (TA) cells with gradually de-
creasing proliferation potential at each serial cloning
step. In contrast, the non-FPC large CFU exhibited lim-
ited recloning ability with cloning efficiency that de-
clined significantly (Figure 3B, P < 0.05) in P2 and P3.
Small CFU of both FPC and non-FPC also displayed
limited cloning ability after three rounds of recloning
(Figure 3B).
Figure 3 Serial passage, clonogenicity and phenotyping of endometrial FPC and non-FPC post labeled day 21. (A) Rate of serial passage
is shown for both large and small CFU of FPC (white) and non-FPC (black). (B) Percentage of large and small CFU at each passage of serial cloning for
FPC (white) and non-FPC (black). Percentage of (C) CD146+/CD140b+ and (D) W5C5+ cells from FPC and non-FPC populations. Bar represents the
mean. Representative dot-plots for co-staining of CD146/CD140b and single staining of W5C5. Single parameter histograms for individual markers
CD146-FITC, CD140b-PE and W5C5-PE. Grey line indicates background fluorescence with isotype matched IgG control Results are reported as mean ±
SEM, n = 7, *P < 0.05, **P < 0.01, ***P < 0.001. CFU, colony-forming units; FPC, fluorescent persistent cells; SEM, standard error of the mean.
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stromal FPC
Previous reports showed the existence of a phenotypically
distinct and relatively rare population of eMSC expressing
CD146+/CD140b+ and W5C5+ [4,23]. The expression of
these two eMSC markers in the endometrial stromal FPC
and non-FPC after D21 chase were analyzed by flow
cytometry (Figure 3C, 3D). The percentage of cells co-
expressing CD146+/CD140b+ was significantly higher in
the endometrial FPC population (53.2 ± 10.1%, n = 7) than
in the non-FPC population (3.7 ± 0.8%, P < 0.001). The
proportion of cells expressing the marker W5C5+ was47.0 ± 7.2% (n = 7) for the FPC and 8.3 ± 4.4% for the non-
FPC; the two values were significantly different (P < 0.01).
The enrichment of these reported markers in the FPC
population indicates that these cells are enriched for
phenotypically defined eMSC.
Passaging efficiency of endometrial stromal FPC
The proliferative potential was determined by serial passa-
ging of the clonally derived FPC and non-FPC until senes-
cence. The number of cells generated by a particular
population and the cumulative cell output are shown in
Table 1. The yield from a single large CFU of endometrial
Table 1 Total cell output from human stromal FPC and
non-FPC CFU
Cell type CFU size Cell yield Length of experiment (days)
FPC Large 1.8 ± 0.3 × 1011 217.7 ± 25.4
Small 3.4 ± 0.6 × 106 57 ± 9.5
Non-FPC Large 9.5 ± 0.3 × 108 98.3 ± 16.2
Small 2.4 ± 0.6 × 106 36.3 ± 4.5
Number of patient samples (n = 3) from 10 to 15 large and 20 to 30 small
individual stromal CFU were serially passaged until senescence. Results are
reported as means ± SEM. CFU, colony-forming units; FPC, fluorescent persistent
cells; SEM, standard error of the mean.
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http://stemcellres.com/content/5/4/84stromal FPC ranged from 1.3 × 1011 to 2.4 × 1011 (167 to
244 days, n = 3), while that from a non-FPC ranged from
6.6 × 108 to 1.4 × 109 (66 to 115 days, n = 3). The total time
required for the large CFU to reach senescence was 217.6 ±
25.4 days for the endometrial stromal FPC and 98.3 ±
16.2 days for the non-FPC. For the small CFU of endomet-
rial stromal FPC, the cell yield was from 2.4 × 106 to 4.5 ×
106 and grew for 57 ± 9.5 days (n = 3). The corresponding
values for non-FPC ranged from 1.5 × 106 to 3.7 × 106 (30Figure 4 The cell proliferation activity (A - E) and G1-phase length (F - H)
photographs of (A) unselected stromal cells, (B) FPC and (C) non-FPC morpholog
lected endometrial stromal cells (grey), clonally derived FPC (white) and non-FPC (
NF cell proliferation assay. The absorbance unit (AU) was measured at a waveleng
were obtained from the same patient. Results are reported as means ± SEM, n = 3
FPC and non-FPC populations followed by time-lapse microscopy within a period
(n= 20 cells), (G) FPC (n= 20 cells) and (H) non-FPC (n= 18 cells) from three patieto 34 days, n = 3) before reaching senescence at 36.3 ±
4.5 days. There was no significant difference in the cell yield
between large or small CFU for FPC (P = 0.10) or non-FPC
(P = 0.10).Endometrial stromal FPC have low proliferation activities
The proliferative activity was assessed using two assays. By
day 5, more unselected endometrial stromal cells were
depicted under the microscope than FPC (Figure 4B) and
non-FPC (Figure 4C) populations. This was supported by
the quantitative trypan blue assay (Figure 4D), which
showed remarkably higher mean cell count for the unse-
lected endometrial stromal cells (29.26 × 104 ± 4.64 × 104)
than the clonally derived FPC on day 15 (2.96 × 104 ±
7.41 × 104, P <0.05, n = 3). The mean cell count for the
endometrial stromal non-FPC was 20.27 × 104 ± 0.74 × 104
and was not different from that of the unselected endo-
metrial stromal cells but higher than that of FPC. A simi-
lar finding was obtained with the fluorescence-based
assay by measuring the DNA content of the cultured
cells (Figure 4E). The absorbance was significantlyof human endometrial stromal FPC and non-FPC. Representative
y in the proliferation assay at day 5. Cell proliferation assessment on unse-
black) after 15 days in culture using (D) trypan blue assay and (E) CyQUANT
th of 480 nm with a reference wavelength of 530 nm. Scale bar: 100 μM. Cells
, *P <0.05. Quantification of the G1 length in Cdt-1-expressing stromal cells of
of 42 hours. The distribution of G1-phase for (F) unselected stromal cells
nt samples. FPC, fluorescent persistent cells; SEM, standard error of the mean.
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(3.58 × 104 ± 0.18 × 104 AU) than the FPC (1.94 × 104 ±
0.43 × 104 AU, P < 0.05, n = 3). No difference was found
between the absorbance for the endometrial stromal non-
FPC (3.43 × 104 ± 0.61 × 104 AU) and the unselected
endometrial stromal cells. Collectively, these findings
together with the passaging efficiency demonstrate the
enrichment of slow-proliferating cells in the endometrial
stromal FPC subset.
G1 phase lengthening in the endometrial stromal FPC
We next examined the length of the G1 phase in the differ-
ent cell populations using a fluorescence unbiquitylation-
based cell cycle indicator, Cdt1. The expression of Cdt1 is
highest in cultured cells in the G1 phase [20]. The expres-
sion of Cdt1 in the unselected endometrial stromal cells,
clonally derived FPC and non-FPC, was monitored at the
single cell level for 42 hours. We analyzed only the Cdt1-
expressing cells that showed a gradual increase in red
fluorescence (entry of G1 phase) followed by a loss of the
fluorescence (transit to the G1/S phase, Additional file 2:
Figure S2A) within the recording period. The endometrial
stromal cells have a doubling time of 24 hours [24]. Here,
we compared the percentage of cells with a G1 phase
longer or shorter than 24 hours in the studied cell popu-
lations. The length of the G1 phase in the endometrial
stromal populations showed a wide distribution. For the unse-
lected stromal cells, 50% of them had a G1 phase > 24 hours
(Figure 4F, n = 20/cell). The proportion of FPC having a
G1 phase > 24 hours (65%, Figure 4G, n = 20/cell) was
higher than that of the non-FPC (44%, Figure 4H,
n = 18/cell). Their difference did not reach statistical
significance, probably due to the small sample size.
The slow proliferation activity of the FPC may be associ-
ated with lengthening of the G1 phase.
Endometrial stromal FPC have greater multipotency
eMSC can differentiate into mesenchymal lineages upon
cultivation in specific induction media [4]. To determine
the multipotent potential of the clonally derived-FPC and
non-FPC, they were induced to differentiate into mesen-
chymal lineages in vitro.
Both populations of stromal cells showed strong pro-
tein expression of the early smooth muscle cell marker
(Figure 5A) αSMA in immunohistochemical staining
and in western blotting when cultured in the myogenic
inducing medium. Quantitative analysis revealed a sig-
nificantly higher mRNA expression of αSMA (ACTA) in
the FPC than in the non-FPC (P < 0.05, Figure 5A).
For osteogenic differentiation (Figure 5B), both popu-
lations of stromal cells stained positive for osteopontin
upon induction and its protein expression level was also
detected by western blotting. The expression of the early
stage osteogenic transcription factor, core binding factoralpha1 (CBFA1), was significantly higher in the FPC than
in the non-FPC (P < 0.01, Figure 5B).
In chondrogenesis-inducing medium, only the FPC
formed micromass pellets while the non-FPC remained
as a monolayer of cells (Figure 5C). Safranin O staining
of the FPC-derived micromass revealed the presence of
sulfated proteoglycan. The cells in the masses possessed
collagen II protein as shown in immunohistochemical
staining and western blotting. Quantitative analysis of the
collagen II transcript showed higher expression in the
FPC population (Figure 5C, P < 0.05).
For the adipogenic lineage, FPC and non-FPC did not
develop lipid-like droplets after induction and failed to
stain with oil red O (data not shown). Both populations
of stromal cells did not stain for the key adipogenic tran-
scription factor, peroxisome proliferation activated re-
ceptor γ (PPARγ), and its protein expression was also
not detected by western blotting (data not shown). How-
ever, quantitative analysis of the transcription factor
CCA-AT/Enhancer Binding Protein alpha (C/EBP-α) re-
vealed significantly higher expression in the FPC popula-
tion (Additional file 7: Figure S3, P < 0.05).
Based on these data, both populations of stromal cells
can differentiate into three of the four mesenchymal lin-
eages studied. In particular, the FPC are significantly
more multipotent as reinforced by the quantitative ana-
lysis of the data, indicating this subset contains more un-
committed progenitor cells.Molecular characteristics of the endometrial stromal FPC
and non-FPC
To gain further insight into the molecular properties of
the two functionally distinct populations, we performed
real-time PCR to determine their expression of genes as-
sociated with pluripotency in human embryonic stem cells
(NANOG, SOX2, OCT4) [25], and self-renewal in somatic
stem cells (BMI-1) [26]. Comparison of the FPC and non-
FPC transcript expression at P1 revealed no differences
for these genes (Figure 6). Interestingly, an up-regulation
trend for the four genes (Figure 6A-D, n = 3) was observed
in cells of the secondary FPC when compared to that of
primary FPC and non-FPC, though the difference had not
yet reached statistical significance (P = 0.10) probably be-
cause of the small sample size.Discussion
This study demonstrates the existence of a specific
population of FPC in the human endometrial stromal
culture. These cells exhibit stem cell characteristics, in-
cluding high proliferation, self-renewal, differentiation
potential and expression of prospective eMSC surface
markers. In addition, the stromal FPC have slow-
proliferating activity associated with lengthening of
Figure 5 Differentiation potential of human endometrial stromal FPC and non-FPC into mesenchymal lineages in vitro. Myogenic
differentiation (A) with αSMA (brown) staining on cells clonally derived from stromal large CFU of FPC and non-FPC. Protein expression and
quantification of αSMA. Relative gene expression level of ACTA by real time PCR. Osteogenic differentiation (B) with osteopontin (brown) staining on
cells clonally derived from stromal large CFU of FPC and non-FPC. Protein bands and quantification expression of osteopontin. Relative gene
expression level of CBFA1 by real-time PCR. Chondrogenic differentiation (C) with safranin-O (red) histochemical staining on cells clonally derived
from stromal large CFU of FPC and non-FPC. Immunofluorescent staining with DAPI (blue) and collagen II (pink) on stromal large CFU of FPC and
non-FPC. Micromass structure depicted from FPC chondrogenic induced cells. Protein bands and quantification expression of collagen II. Relative gene
expression level of COL2A1 by real-time PCR. mRNA expression levels were normalized to 18S. Expression of the control was set as one. Control cells
stained for lineage markers shown in inset and western blots are unselected stromal cells grown in culture medium with fetal bovine serum for four
weeks. Scale bar: 200 μm, including inset. Results shown from a single sample representative of three patients. Results are reported as means ± SEM for
western blotting (n = 3) and for real-time PCR (n = 6), *P < 0.05, **P < 0.01. αSMA (ACTA), alpha smooth muscle actin; CBFA1: core binding factor 1; CFU,
colony-forming unit; COL2A1: collagen type II alpha 1; FPC, fluorescent persistent cells; SEM, standard error of the mean.
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http://stemcellres.com/content/5/4/84their G1 phase while non-FPC have restricted prolifera-
tive ability and a lack of specific markers associated with
stemness, pluripotency suggesting that these cells are
more differentiated cells and reaching replicative sen-
escence. Many groups have used various assays, such
as clonogenicity [19], side-population phenotype [27,28]
and surface markers [4,23] to identify and characterize
eMSC. However, to our knowledge there are no studies
showing the existence of slow-cycling stem/progenitor
cells in the human endometrium.The classical approach of identifying slow-cycling som-
atic stem cells is using the bromouridine labeling tech-
nique, in which the stem cells retain the label after long
term chase. However, the detection of the incorporated
bromouridine requires fixation of the cells, making isola-
tion of viable label-retaining cells for functional studies
impossible. There is a need to develop a simple method
for isolation of viable somatic stem/progenitor cells, which
may be used for stem/progenitor cells without known
surface markers. Here, we demonstrated that fluorescent
Figure 6 Expression of pluripotent and self-renewal genes. The relative gene expression levels of (A) NANOG, (B) SOX2, (C) OCT-4 and (D)
BMI-1 of passage 1 and 2 (P1, P2) FPC (white bars) and non-FPC (black bars) in comparison to human embryonic stem cells (hESC, grey bars) as
positive control. Results are reported as means ± SEM, n = 3. FPC, fluorescent persistent cells; SEM, standard error of the mean.
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endometrial cells with stem/progenitor cell properties.
In pancreatic stem cells, the uptake of the fluorescent
nanoparticles does not affect proliferation and gene ex-
pression, and the nanoparticles are transmitted equally to
the daughter cells during cell divisions [17]. We have also
tried to label the endometrial stromal cells with two other
reported tracking dyes, namely PKH26 [29] and Vybrant
CM-Dil™ [30], and found them unsuitable for the endo-
metrial stromal cells; the PKH26 signal was lost after
culturing for 21 days, while the Vybrant™ CM-Dil label
became undetectable after trypsinization for flow cytome-
try analysis (unpublished data).
Several lines of evidence indicate FPC are candidate
eMSC. Firstly, the endometrial stromal FPC have high
efficiency in developing into colonies containing cells
with proliferative potential higher than non-FPC. More
importantly, cells from the FPC-derived large CFU can
undergo substantial self-renewal, producing tertiary and
higher order of clones. We consider the FPC from these
large CFU as stem/progenitor cells, as they generate qua-
ternary clones, defining the adult stem cell status with the
ability to proliferate, self-renew and produce a largenumber of differentiated cells [31]. FPC-derived small
CFU are initiated by TA cells, since they exhausted after
several rounds of serial cloning. Thus, they were not fully
characterized in this study.
Secondly, the clonogenic efficiency of the FPC increased
whereas that of the non-FPC decreased in the secondary
and tertiary passages. After isolation by flow cytometry
(P1), the colony-forming ability of FPC was slightly higher
than that of the non-FPC. A large significant variation be-
tween samples was observed, which may have masked any
significant difference. The significant increase of clono-
genic activity in the subsequent two passages (P2 and P3)
was associated with an up-regulated expression of self-
renewal and pluripotent genes. The cells derived from the
large CFU of FPC displayed a much higher proliferation
activity at clonal density after serial subcloning. Re-plating
of the single FPC may trigger candidate eMSC to self-
renewal exhibiting high proliferative potential and main-
taining a durable capacity of generating progenies through
expansion in subsequent passages. The nature of the trig-
ger is not known, although micro-environmental niche
is known to affect cell-fate decision, such as self-renewal
versus differentiation [10,32]. Nonetheless, our current
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ness of FPC. Therefore, long-term in vitro culture of FPC
leads to gradual loss in the proliferation potential, as
shown by the stepwise reduction in the colony number
with increase in passaging. A similar finding was also
observed in small CFU of FPC at P2. These small CFU
derived from TA cells displayed limited proliferative ability
and quickly exhausted in later passages.
Thirdly, the endometrial stromal FPC demonstrated
greater multipotent potential than the non-FPC. Al-
though FPC could not fully differentiate into adipocytes
because they fail to express the late adipogenic marker
PPARγ [33], we did find both the FPC and non-FPC
clones possessed the ability to develop into myogenic,
osteogenic and chondrogenic lineage cells. Quantitative
assays for expression of these lineage specific markers
demonstrated that the FPC exhibited significantly
greater multi-lineage potential than the non-FPC. The
identification of candidate eMSC with high differenti-
ation efficiency may be useful for future tissue engineer-
ing applications [34].
Fourthly, a high proportion of FPC expressed surface
markers of eMSC. Studies reveal that human eMSC
expressing the markers CD146+/CD140b+ and W5C5+ ex-
hibit properties of bone marrow (BM) derived MSCs [3].
Endometrial stromal FPC are enriched with cells W5C5+
(47%) and CD146+/CD140b+ (53%). Given the perivascu-
lar localization of both these markers in the endometrium,
it is highly likely that our FPC are BM derived. Consistent
with the observed properties of FPC in this study, endomet-
rial stromal CD146+/CD140b+ or W5C5+ populations also
have high colony forming ability and multi-lineage poten-
tials. The overall cloning efficiency (CE) of FPC found in
our study was three-fold lower than that reported for the
CD146+/CD140b+ cells [4]. However, we noticed that the
CFU size for CD146+/CD140b+ clones was 10-fold lower
than that in our study. The difference in the definition of
CFU size may account for the lower cloning efficiency ob-
served in stromal FPC. The discovery of the single marker
W5C5, or recently identified as SUSD2, offers a simpler
method for the isolation of the prospective eMSC [35].
Comparative studies have shown higher cloning efficiency
for the magnetic beaded W5C5+ cells than the FACS
sorted W5C5+ cells [23]. Unpublished observations from
our group revealed high variation in the cloning efficiency
of W5C5+ cells among human endometrial samples. Fur-
thermore, the duration for clonogenic assessment of the
W5C5+ cells in vitro was two to three times longer and the
sizes of the colonies were smaller than those in the present
study. Clonal studies have shown the endometrial stro-
mal cell proliferation potential (clonogenic size) corre-
lates with cell potency, both in healthy and pathologic
conditions [3]. It remains to be determined whether
these eMSC subsets represent different intermediatedevelopmental stages of the same stem/progenitor cells
or independent cell lineages which have originated from
different stem/progenitor cell populations.
In this study, we used Cdt1-RFP to determine the length
of the G1-phase in single cells, and found that a high pro-
portion (65%) of FPC have a prolonged G1 phase. This
finding is similar to the percentage of CD146+/CD140b+
and W5C5+ cells in the FPC population. Human placenta
derived-MSCs [36] and brain parenchymal progenitors
[37] also display a long G1 phase. A lengthening of the G1
cell cycle in the murine embryonic and neural stem cells
correlates with differentiation [38,39]. On the other hand,
a prolonged G1 transit is a property of mouse fetal liver
hematopoietic stem cells [40] and brain parenchymal pro-
genitors [37]. Available evidence suggests the environmen-
tal niche contributes to cell regulation in somatic stem
cells. Hyaluronan maintains the slow-cycling property of
MSCs by prolonging the G1 [36]. The expression of hya-
luronan synthase in human endometrium can potentially
be responsible for the hyaluronan accumulation in slow
cycling stromal cells [41]. In contrast, wound injury induces
the brain parenchyma progenitors to enter the cell cycle,
shortening the normally long G1 phase [37].
Slow-cycling and or quiescent state is important for
maintaining the stem cell function of somatic stem cells.
Continuous proliferation results in exhaustion of the stem
cell function [32]. Our findings show that the slow
cycling property of the endometrial stromal FPC does not
affect their stem cell properties in terms of clonogenicity,
proliferative potential and multipotency. In conditions yet
to be defined, the slow-cycling FPC undergo asymmetrical
division producing the TA cells, which are responsible for
the propagation of progenies.
Conclusions
In conclusion, we demonstrated a candidate population of
endometrial stromal cells with characteristics of slow-cycling
and exhibiting common hallmark properties of somatic
stem cells. The established in vitro method provides an al-
ternate platform for future analyses of putative endomet-
rial stromal stem/progenitor cells. It can also be used for
isolating putative somatic stem/progenitor cells in other
adult tissues which do not have defined surface marker(s).
The existence of endometrial stem/progenitor cells res-
iding in inactive and postmenopausal [3] endometrium
raises the possibility that these cells are slow-cycling. The
current established technique can be used for the isolation
of slow-cycling cells from women with irregular or no
cycles, so the molecular mechanisms involved in the self-
renewal of endometrial stem/progenitor cells can be eluci-
dated. Furthermore, application of the FPC technique in
characterizing the putative endometrial epithelial stem/
progenitor cells may be of use, as there has been limited
development within this field.
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Additional file 1: Figure S1. Gating strategy for flow-cytometry sorting
of fluorescence persisting cells. Dot plot setup for (A) exclusion of debris
from live cells based on the Forward Scatter (FSC) and Side Scatter (SSC)
plot. (B) Cell properties; SSC area (SSC-A) versus SSC height (SSC-H), to
gate out cell doublets and aggregates and ensure the signal arises from
single cell. Qtracker® dye was recognized by allophycocyanin (APC) laser.
Single parameter histogram for (C) positive control using freshly stained
cells (same gate set approximately 98% for APC, right) and (D) negative
control using unstained cells (gate set 0% for APC, right). (E) Cells were
sorted using the gating for isolation of the two populations: left for
fluorescence˗ (non-FPC) and right for fluorescence+ (FPC) expression.
Additional file 2: Figure S2. Different patterns of G1 phase within a
period of 42 hours. The changes of Cdt1 red fluorescence protein in
endometrial stromal cells; (A) appearance and disappearance within the
recording period, (B) continuous, (C) fluorescence seen at the beginning
or (D) fluorescence still observed at the end of the recording. Images are
representative of one experiment.
Additional file 3: Table S1. Induction for differentiation of
mesenchymal lineages and the detection of specific markers using
histochemical staining, immunofluorescence and real-time PCR.
Additional file 4: Table S2. List of primary and secretory antibodies
used for immunohistochemistry (IHC) and immunofluorescent (IF)
staining.
Additional file 5: Table S3. List of primary and secondary antibodies
used for western blotting.
Additional file 6: Table S4. Pluripotent and self-renewal genes. List of
Taqman probes used for real-time PCR.
Additional file 7: Figure S3. Differentiation potential of human endometrial
stromal FPC and non-FPC into adipogenic lineage. Adipogenic differentiation on
cells clonally derived from stromal large CFUs of FPC and non-FPC. Relative
gene expression level of C/EBPα. mRNA expression levels were normalized
to 18X. Expression of control was set as one. Control is unselected stromal
cells grown in culture medium with fetal bovine serum for four weeks.
Results are reported as mean ± SEM (n = 6), *P <0.05. Abbreviation: C/EBPα,
CCAAT-enhancer-binding protein α.
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AU: absorbance unit; BM: bone marrow; BSA: bovine serum albumin;
C/EBPα: CCAAT-enhancer-binding protein α; CBFA1: core binding factor 1;
Cdt1-RFP: CdC 10 dependent transcript 1 red fluorescent protein;
CFU: colony-forming units; COL2A1: collagen type II alpha 1; (D)MEM:
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